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OPEN
ORIGINAL ARTICLE
Timeline of changes in appetite during weight loss with
a ketogenic diet
S Nymo1, SR Coutinho1, J Jørgensen1, JF Rehfeld2, H Truby3, B Kulseng1,4 and C Martins1,4
BACKGROUND/OBJECTIVE: Diet-induced weight loss (WL) leads to increased hunger and reduced fullness feelings, increased
ghrelin and reduced satiety peptides concentration (glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK) and peptide YY (PYY)).
Ketogenic diets seem to minimise or supress some of these responses. The aim of this study was to determine the timeline over
which changes in appetite occur during progressive WL with a ketogenic very-low-energy diet (VLED).
SUBJECTS/METHODS: Thirty-one sedentary adults (18 men), with obesity (body mass index: 37 ± 4.5 kg m− 2) underwent 8 weeks
(wks) of a VLED followed by 4 wks of weight maintenance. Body weight and composition, subjective feelings of appetite and
appetite-related hormones (insulin, active ghrelin (AG), active GLP-1, total PYY and CCK) were measured in fasting and
postprandially, at baseline, on day 3 of the diet, 5 and 10% WL, and at wks 9 and 13. Data are shown as mean± s.d.
RESULTS: A signiﬁcant increase in fasting hunger was observed by day 3 (2 ± 1% WL), (Po0.01), 5% WL (12 ± 8 days) (Po0.05) and
wk 13 (17 ± 2% WL) (Po0.05). Increased desire to eat was observed by day 3 (Po0.01) and 5% WL (Po0.05). Postprandial
prospective food consumption was signiﬁcantly reduced at wk 9 (16 ± 2% WL) (Po0.01). Basal total PYY was signiﬁcantly reduced
at 10% WL (32 ± 8 days) (Po0.05). Postprandial active GLP-1 was increased at 5% WL (Po0.01) and CCK reduced at 5 and 10% WL
(Po0.01, for both) and wk 9 (Po0.001). Basal and postprandial AG were signiﬁcantly increased at wk 13 (Po0.001, both).
CONCLUSIONS: WL with a ketogenic VLED transiently increases the drive to eat up to 3 weeks (5% WL). After that, and while
participants are ketotic, a 10–17% WL is not associated with increased appetite. However, hunger feelings and AG concentrations
increase signiﬁcantly from baseline, once refeeding occurs.
International Journal of Obesity (2017) 41, 1224–1231; doi:10.1038/ijo.2017.96
INTRODUCTION
Obesity has reached epidemic proportions worldwide and is
associated with negative public health consequences and large
socioeconomic costs.1 A weight loss (WL) between 5 and 10% of
baseline weight, if sustained, can have large health beneﬁts by
preventing or improving several obesity-related risk factors and
comorbidities.2 Even though this can be achieved in the short-
term with lifestyle interventions,3 most adults will experience
weight regain in the long term.3–5
Maintaining lost weight is physiologically challenging, as diet-
induced WL is associated with compensatory responses on both
sides of the energy balance equation.6 These responses are driven
by a cross talk between the gut and the brain, leading to an
increase in appetite and reduction in satiety,7–9 concomitant with
an overall reduction in energy expenditure.10–12 These mechan-
isms can reduce WL rate and increases the risk of relapse.9 An
increase in ghrelin plasma concentration13–15 and a reduction in
the concentration of several satiety hormones, such as peptide YY
(PYY), glucagon-like peptide-1 (GLP-1)13,16–18 and cholecystokinin
(CCK)13,19 has also been reported with diet-induced WL.
To our knowledge, no studies to date have determined how
appetite is affected with progressive WL. With a WL of only 1–2 kg
being shown to increase subjective feelings of hunger,20 and a WL
of 0.8 kg associated with an increase in postprandial total ghrelin
and a reduction in subjective feelings of fullness,21 it is not
surprising that adults ﬁnd WL maintenance extremely hard.
However, when carbohydrates and/or energy (using a very-low-
energy diet (VLED)) are restricted sufﬁciently to induce ketosis, the
increase in appetite seen with WL appears to be absent.12,22 This
has contributed to the generalised idea that ketogenic diets are
easy to follow. Most of the studies looking at the impact of WL
induced with ketogenic diets on appetite have, nevertheless, been
done in females22 and none has investigated how long time does
it take for appetite suppression to occur under ketogenic diets.
Therefore, the primary aim of this study was to assess the timeline
over which changes in both subjective feelings of appetite and
appetite-related hormones are activated during WL with a
ketogenic VLED. A secondary aim was to assess if males and
females respond differently.
MATERIALS AND METHODS
Participants
Healthy adults with obesity (30oBMI o45 kg m− 2) were recruited via
newspaper advertising serving the community of Trondheim, Norway. The
study was approved by the regional ethics committee (Ref., 2012/1901).
The study was registered in ClinicalTrial.gov (NCT01834859), and
conducted according to the guidelines laid down in the Declaration of
Helsinki. All participants provided written informed consent before
commencement.
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Participants were required to be weight stable (o2 kg body weight
change over the last 3 months), not currently dieting to lose weight, and
with a sedentary lifestyle (not engaged in strenuous work or in regular
brisk leisure time exercise more than once a week or in light exercise for
more than 20 min per day in more than 3 times per week). Due to the
known effect of phase of menstrual cycle on appetite23 females had to be
postmenopausal or taking hormonal contraceptives. Exclusion criteria
were pregnancy, breastfeeding and clinically signiﬁcant illness including
diabetes, previous WL surgery and/or medication known to affect appetite/
metabolism or induce WL.
Study design
This was a longitudinal intervention study with repeated measurements.
Participants were provided with an 8-week ketogenic VLED, followed by
4 weeks of weight stabilisation, and were requested not to change their
physical activity levels throughout the study (Supplementary Figure I).
Detailed protocol
Weight loss phase. Participants followed for 8 weeks a ketogenic VLED
(Allevo, Karo Pharma AS, Sweden) with 550/660 kcal per day for females
and males, respectively (macronutrient composition: carbohydrates 42%,
protein 36%, fat 18% and ﬁbre 4%). No energy ﬂuids were allowed ad
libitum. Intake of low-starch vegetables (max 100 g per day) was
encouraged, to provide dietary ﬁbre.
Weight stabilisation phase
At week 9, participants were gradually introduced to normal food, while
reducing intake of the VLED products. An individual diet plan was
prescribed by a trained dietician tailored to individual energy requirements
(measured resting metabolic rate (RMR) × physical activity level (PAL)
(extracted from individual physical activity monitors (BodyMedia, Sense-
Wear, Pittsburgh, PA, USA) at week 8)), with 15–20% protein, 20–30% fat
and 50–60% carbohydrates, aimed at weight stabilisation.24
Objective measures of compliance
Diet: Participants met every week for an individual 20 min consultation
with a dietician, to review their food records. Urine acetoacetic acid
concentration was also measured weekly, using Ketostix reagent strips.
Participants who were not ketotic on more than one occasion were
considered not compliant and were excluded from the analysis.
Concentration of plasma β-hydroxybutyric acid (β-HB) in the fasting state
was also measured with a Ketone Body Assay Kit (Mark134, Sigma-Aldrich,
St Louis, MO, USA) at baseline, day 3, 5 and 10% WL and weeks 9 and 13.
Physical activity: Armbands were used for 7 days at baseline, weeks 4, 8 and
12. Data were considered valid if participants wore the device for ⩾ 4days,
including at least 1 weekend day, on more than 95% (22.8 h per day) of the
time.25
Data collection
The following measurements were performed in fasting at baseline, day 3
of the VLED, when each individual participant reached 5 and 10% WL, and
at weeks 9 (the day immediately after the end of the VLED) and 13.
Body weight and composition. Air displacement plethysmography
(BodPod, COSMED, Rome, Italy) was used.
Appetite measures. Subjective appetite feelings (hunger, fullness, desire to
eat and prospective food consumption (PFC)) were measured using a
validated 10 cm visual analogue scale26 and blood samples were collected
in fasting and every 30 min (0, 30, 60, 90, 120 and 150 min) after a
standardised breakfast (600 kcal: 17% protein, 35% fat and 48%
carbohydrates), for a period of 2.5 h. Plasma samples were analysed for
active ghrelin (AG), total PYY, active GLP-1 and insulin using a Human
Metabolic Hormone Magnetic Bead Panel (LINCOplex Kit, Millipore,
St Louis, MO, USA) and CCK using an ‘in-house’’ RIA method27 (intra-
and inter-assay coefﬁcient of variation were o10% and o20% for AG,
GLP-1 and PYY; o10% and o15% for insulin and o5% and o15% for
CCK, respectively).
Power calculation
Sample size estimation was based on expected changes (from baseline) in
fasting AG plasma concentration overtime (day 3: 27; 5 and 10%: 0; week 9: 4
and week 13: 53 pmol l−1). Having into consideration that no previous
studies have been done in this area, we used data from Sumithran et al.12 for
weeks 9 and 13 and hypothesised that there would be an increase in AG on
day 3 (approximately half of that seen on week 13) and no changes at 5 and
10% WL (given that participants would be under ketosis). For a SD of 89
pmol l− 1,12 a power of 80%, a signiﬁcance level of 5% and assuming a low
correlation between time points (r=0.3), 32 participants would be necessary.
Statistical analysis
Statistical analysis was performed with SPSS version 22 (SPSS Inc., Chicago, IL,
USA), and data presented as estimated marginal means± s.e.m., with the
exception of BMI, age, average time to achieve 5 and 10% WL and WL (%) at
day 3, weeks 9 and 13, where means± s.d. are given. Statistical signiﬁcance
was set at Po0.05. Data were analysed using linear mixed-effects models,
with restricted maximum likelihood estimation, including ﬁxed effects for
time and sex, and their interaction. Bonferroni correction was used for post
hoc pairwise comparisons. The Benjamini—Hochberg method, which
controls for the false discovery rate was used to adjust for the fact that
we have looked at a large number of outcome variables.28 Analyses of
fasting and 2.5-h postprandial hormone proﬁle for AG and subjective
feelings of hunger were also carried out by linear mixed-effects models (ﬁxed
effects for sampling time points (0, 30, 60, 90, 120 and 150 min), time
(baseline, day 3, 5 and 10% WL and wks 9 and 13), sex and interactions).
Weight at baseline was used as a covariate in the linear mixed-effects
models when looking at changes in subjective and objective measures of
appetite. Given that this did not change the signiﬁcance of the results; the
unadjusted values are presented. Total area under the curve for subjective
feelings of appetite and appetite hormones was calculated from 0 to
150 min using the trapezoid rule. Participants with available data on at
least three out of the six time points were considered completers.
RESULTS
Participants
Thirty-three participants met study entry criteria and 31 (13
females, 6 postmenopausal) were included in the analysis (one
female withdrew due to personal reasons and one male due to
not tolerating the VLED (veriﬁed incidence of vomiting, dizziness
and fatigue)). Completers had an average BMI of 36.7 ± 4.5 kg m− 2
and a mean age of 43 ± 10 years. Males were heavier and with
greater FFM (kg) than females (Po0.01 and Po0.001, respec-
tively), but there were no signiﬁcant differences in age or BMI
between sexes (Supplementary Table I ).
Objective measures of compliance
Diet: Compliance with the VLED was excellent and no participant
was excluded based on not being compliant. Participants were
already ketotic at day 3 (0.60 ±0.13mmol l−1 of β-HB), even though
β-HB plasma concentrations were only signiﬁcantly increased,
compared with baseline, at 5% WL (12± 8 days) (Po0.001 for all,
males and females), and continued increased up to week 9 (16±2%
WL) (Po0.001 for all, males and females) (Figure 1).
Physical activity: All participants were sedentary at baseline and
there were no signiﬁcant changes over time in any PA variable
studied (Supplementary Table II ).
Body weight and composition
A signiﬁcant main effect of time, sex and interaction (Po0.001,
Po0.05 and Po0.001, respectively) was found for body weight.
WL was already signiﬁcant (Po0.001) on day 3 in all participants
and males (2 ± 1% WL for both) and body weight continued
decreasing progressively, but with no signiﬁcant differences
between week 9 and 13 (16 ± 2% and 17 ± 2% WL, respectively)
(Figure 2a). About 5% WL was achieved on day 12 ± 6 (11 ± 5 and
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15± 7, for males and females, respectively) and 10% WL on day
32± 8 (28 ± 7 and 37± 6 for males and females, respectively).
Overall WL (kg) was signiﬁcantly larger in males compared with
females (Po0.001), and also at weeks 9 and 13 (Po0.001 for
both). When WL was expressed in % there were no overall
signiﬁcant sex differences (P= 0.053), but at week 9 (Po0.01)
males had a signiﬁcantly larger WL than females.
FM (kg) decreased signiﬁcantly for the ﬁrst time after 5% WL
(12 ± 8 days) (Po0.001 for all participants, Po0.01 for males and
Po0.05 for females) and was signiﬁcantly lower than baseline at
all the other subsequent time points (Figure 2b).
There was a signiﬁcant decrease in FFM (kg) for the ﬁrst time at
week 9 (16 ± 2% WL), in all participants and in males (5.8 ± 1.0 kg
and 8.3 ± 1.4 kg, respectively, Po0.001 for both). FFM (kg) was
never signiﬁcantly lower than baseline in females (Figure 2b).
Appetite feelings
Fasting feelings of appetite in all participants and by sex are
reported in Figure 3.
A signiﬁcant main effect of time, but no main effect of sex or
interaction, was found for hunger and desire to eat in fasting
(Po0.01, for both). Feelings of hunger in fasting were signiﬁcantly
increased, compared to baseline, at day 3 (2 ± 1% WL) (Po0.01),
after 5% WL (12 ± 8 days) (Po0.05) and at week 13 (17 ± 2% WL)
(Po0.05) in all participants. In women, fasting hunger was
signiﬁcantly increased on day 3 and week 13 (Po0.01 and
Po0.05, respectively). In men, no signiﬁcant changes were seen at
any time point. Feelings of desire to eat were signiﬁcantly
increased at day 3 and after 5% WL in all participants (Po0.01 and
Po0.05, respectively) and males (Po0.05 for both). For feelings
of PFC in fasting, there was a signiﬁcant main effect of time only
(Po0.05). However, no signiﬁcant differences were found
between baseline and any other time point. Men reported greater
feelings of PFC in fasting overall (6.8 ± 0.4 vs 5.5 ± 0.4 cm, P= 0.05).
No signiﬁcant main effect of time, sex or interaction was found for
feelings of fullness in fasting.
AUC for subjective feelings of appetite overtime is reported in
Figure 4. A signiﬁcant main effect of sex, but no main effect of time
or interaction was found for hunger AUC (Po0.01). A signiﬁcant
main effect of time and sex was found for fullness AUC (Po0.01
and Po0.001, respectively), desire to eat (Po0.05 for both) and
PFC (Po0.001 and Po0.01, respectively). No signiﬁcant differences
were found between baseline and any other time point for hunger
AUC, desire to eat or fullness. PFC AUC was signiﬁcantly lower at
week 9 (16±2% WL), compared with baseline in all participants and
females (Po0.01 and Po0.05, respectively). Males had signiﬁcantly
Figure 1. Basal plasma concentration of β-hydroxybutyric acid over time in all participants, males and females. Results presented as estimated
marginal means± s.e.m. A signiﬁcant main effect of time was found for β-hydroxybutyrate (Po0.001). Symbols denote signiﬁcant differences
from baseline in all participants ***Po0.001, males &&&Po0.001 and females ###Po0.001. WL, weight loss
Figure 2. Changes in body weight (a) and body composition (b) over time in all participants, males and females. Results are presented as
estimated marginal means± s.e.m. Symbols denote signiﬁcant changes from baseline (all participants: ***Po0.001 for body weight and
FM and ###Po0.001 for FFM; males: &&&Po0.001 for FFM and €€€Po0.001, and €€Po0.01 for FM and females: $$$Po0.001 and $Po0.05 for
FM). FFM, fat-free mass; FM, fat mass; WL, weight loss.
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higher overall hunger AUC (582.2 ± 52.4 vs 267.18±61.8 cmmin−1,
respectively), PFC AUC (904.1 ± 80.9 vs 459.8 ± 95.2 cmmin−1,
respectively) and desire to eat (689.1 ± 72.1 vs 380.1 ±
84.8 cmmin− 1, respectively), compared to females. Females had
signiﬁcantly higher fullness AUC (832.6±35.9 vs 1149.7±
42.3 cmmin− 1, respectively), compared to males.
Fasting and 2.5-h postprandial hunger feelings can be seen in
Supplementary Figure II.
Appetite regulating hormones
Basal plasma concentration of appetite-related hormones over-
time is reported in Figure 5. There was a signiﬁcant main effect of
time, sex and interaction (Po0.001, Po0.01, Po0.05, respec-
tively) for basal AG. There was a signiﬁcant increase in basal AG
compared to baseline only on week 13 (16 ± 2% WL) in all
participants, females (Po0.001 for both) and males (Po0.05).
Basal AG concentration was signiﬁcantly lower overall in males
compared with females (69.2 ± 8.3 vs 110.3 ± 10.2 pmol l− 1,
respectively). No signiﬁcant main effects of time, sex or interaction
were found for basal active GLP-1 or CCK. A signiﬁcant main effect
of time (Po0.05), but no main effect of sex or interaction was
found for basal total PYY. A signiﬁcant decrease in basal active
GLP-1 was seen at 10% WL (32 ± 8 days) and at week 9 (16% WL),
compared with baseline, in males only (Po0.05 for both).
Figure 3. Subjective feelings of appetite (a: hunger, b: fullness, c: desire to eat and d: PFC) in fasting, over time, in all participants, males and
females. Results presented as estimated marginal means± s.e.m. Symbols denote signiﬁcant differences from baseline in all participants:
**Po0.01 and *Po0.05, males: &Po0.05 and females: ##Po0.01 and #Po0.05. PFC, prospective food consumption; WL, weight loss.
Figure 4. AUC for subjective feelings of appetite (a: hunger, b: fullness, c: desire to eat and d: PFC) over time in all participants, males and
females. Results presented as estimated marginal means± s.e.m. Symbols denote signiﬁcant differences from baseline in all participants:
**Po0.01 and females: #Po0.05. AUC, total area under the curve; PFC, prospective food consumption; WL, weight loss.
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A signiﬁcant reduction in basal PYY was present only after 10% WL
(32 ± 8 days), when compared with baseline, in all participants and
males (Po0.05 for both). A signiﬁcant main effect of time
(Po0.001), but no effect of sex or interaction was found for basal
insulin. There was a signiﬁcant reduction in basal insulin,
compared to baseline, for the ﬁrst time at day 3, in all participants,
males and females (Po0.001, Po0.01 and Po0.05, respectively),
which persisted thereafter.
AUC for appetite-related hormones overtime is reported in
Figure 6. A signiﬁcant main effect of time was found for AG AUC
(Po0.001). AG AUC was signiﬁcantly increased at week 13 (17±2%
WL) in all participants, males and females (Po0.001 for all
participants and Po0.05 for males and females). A signiﬁcant
main effect of time, but no sex or interaction, was seen for active
GLP-1, insulin and CCK AUC (Po0.01, Po0.001 and Po0.001,
respectively). Active GLP-1 AUC was only signiﬁcantly increased
after 5% WL (12± 8 days) in all participants (Po0.01). In females,
GLP-1 AUC was signiﬁcantly higher than baseline at 5% and week 9
(16±2%WL) (Po0.05, for both). CCK AUC was signiﬁcantly reduced
at 5 and 10% WL (32±8 days) (Po0.01 for both), and week 9
(Po0.001) in all participants and 5% WL and week 9 in males
(Po0.01 for both). A signiﬁcant main effect of time (Po0.05), but
no main effect of sex or interaction, was found for PYY AUC. There
was only a signiﬁcant increase between baseline and week 9
(Po0.05) in females. Insulin AUC was signiﬁcantly reduced at all
time points except day 3 in all participants and males, (Po0.001 for
all) and in females at 5 and 10% WL and week 9 (Po0.05 for all).
Fasting and 2.5-h postprandial AG concentrations can be seen
in Supplementary Figure III.
DISCUSSION
In this novel study investigating progressive changes in appetite
in adults during a ketogenic WL diet, both subjective feelings of
hunger and desire to eat were signiﬁcantly increased at day 3
(2 ± 1% WL), but were not accompanied by signiﬁcant changes in
physiological appetite hormones except for insulin. This occurred
despite participants being already ketotic (β-HB plasma concen-
tration 0.60 ± 0.13 mmol l− 1). Previous studies looking at the
impact of an acute period of energy restriction on appetite in
people with normal weight and overweight (ranging from 1 to
4 days; between 60 and 85% energy restriction and inducing a WL
between 0.8 and 2.4 kg) report an increase in feelings of hunger
(desire to eat and PFC), both in the fasting and postprandial
state.29–32 Interestingly, these were not accompanied by changes
in either AG,29 total ghrelin31,32 or GLP-1,29 which is in line with
our ﬁndings. However, the study from Pasiakos et al.21 showed a
signiﬁcant increase in postprandial total ghrelin after 2 days on a
321 kcal diet in individuals with normal weight (12 males and 1
female). The different hormone fraction, lower BMI, lower energy
intake and different sex distribution compared to our study
probably accounts for some of these differences. However, in our
study sex responses were apparent. Males (which would be more
easily comparable with Pasiakos and colleagues study33), dis-
played no changes in AG.21 Unfortunately, none of the previously
mentioned studies measured ketosis during WL.
After 5% WL (12 ± 8 days), feelings of hunger and desire to eat
in fasting remained elevated, GLP-1 AUC had increased signiﬁ-
cantly and CCK AUC was signiﬁcantly reduced. After 10% WL
(32 ± 8 days), no signiﬁcant changes in subjective feelings of
Figure 5. Basal plasma concentrations of appetite-related hormones (a: active ghrelin (AG), b: GLP-1, c: CCK, d: PYY and e: insulin) over time in
all participants, males and females. Results presented as estimated marginal means± s.e.m. Symbols denote signiﬁcant differences from
baseline in all participants: ***Po0.001 and *Po0.05, males: &&&Po0.001, &&Po0.01 and &Po0.05, and females: ###Po0.001 and #Po0.05.
CCK, cholecystokinin; GLP-1, glucagon-like peptide-1; PYY, total peptide YY; WL, weight loss.
Changes in appetite during weight loss
S Nymo et al
1228
International Journal of Obesity (2017) 1224 – 1231
appetite were reported, while basal GLP-1 (in males only), basal
PYY (in all and males) and CCK AUC (in all) were signiﬁcantly
reduced. Previous studies using ketogenic diets and inducing a
similar WL (6–8%) have systematically shown no change in hunger
feelings.18,34–39 Even though some of these studies report a
signiﬁcant increase in fullness feelings (both fasting and
postprandial),36,38 others report no changes in feelings of fullness
in the fasting state after WL.34,35,37
A study by Adams et al.,16 where participants with obesity
(males and females) underwent 6 weeks of a VLED (7% WL),
reported a reduction in hunger at 90 and 120 min, an increase in
fullness at 120 min postprandial, as well as a decrease in
postprandial total GLP-1 (but no changes in fasting). Diepvens
et al.39, where females with overweight experienced an 11% WL
with a VLED, reported a signiﬁcant reduction in basal concentra-
tion of AG and no changes in CCK or GLP-1 concentration (either
fasting or postprandial). Similar to us, Soenen et al.18 reported a
signiﬁcant reduction in basal concentration of PYY after a 6% WL
(4 weeks VLED).
A recent meta-analysis by Gibson et al. reported that losing
weight with a ketogenic diet is associated with a reduction in
hunger and increase in fullness feelings. All but one of the studies
included in the analyses had average β-HB plasma concentration
around 0.50 mmol l− 1.22 It is surprising that hunger feelings in
fasting in our study were increased on day 3 and 5% WL, but not
at 10% WL, even though β-HB concentration did not differ from
5% WL. The reasons for this mismatch between β-HB concentra-
tion and subjective appetite feelings are unknown. However, it
can be that participants got used to feeling hungry and that this
perception therefore was attenuated overtime. Moreover, a recent
review has suggested that other factors such as free fatty acids,
reactive oxygen species and microbiota may also play a role.40
At week 9, with a 16 ± 2% WL and ketosis, no changes in
subjective feelings of appetite were seen, with the exception of
PFC AUC, which was reduced compared to baseline in all
participants and females. Basal active GLP-1 was signiﬁcantly
reduced in males and GLP-1 AUC was increased in females, while
CCK AUC was reduced in all participants and males. Only a few
studies have looked at the impact of a WL410% under ketosis on
appetite.12 In the systematic review and meta-analysis from
Gibson et al.22, a signiﬁcant increase in fullness, and decrease in
hunger feelings were reported while ketotic, with a WL ranging
from 5 to 12.5 kg. After 4 weeks of weight stabilisation and
without ketosis, the only signiﬁcant changes observed were
increased hunger feelings in fasting (in all participants and
females) and increased basal and postprandial
concentration of AG.
Sumithran et al.12, in a similar WL intervention, reported no
changes in subjective feelings of appetite and a signiﬁcant
decrease in basal active GLP-1, but different from our study a
signiﬁcant decrease in basal PYY and CCK, and a signiﬁcant
decrease in postprandial concentration of PYY at week 9 under
ketosis. After 2 weeks of weight stabilisation and no ketosis,
appetite feelings were increased. Both basal and postprandial
concentration of AG were also increased, which is in line with our
ﬁndings. Opposite to our ﬁndings, both basal active GLP-1 and
CCK plasma concentration, and postprandial PYY and CCK
concentration were reduced.10 This discrepancy may be due to
differences in the duration of the weight stabilisation period and/
or lack of power. It is possible that more than 2 weeks of weight
stabilisation are needed for the concentration of satiety hormones
Figure 6. AUC for appetite-related hormones (a: active ghrelin (AG), b: GLP-1, c: CCK, d: PYY and e: insulin) over time in all participants, males
and females. Results presented as estimated marginal means± s.e.m. Symbols denote signiﬁcant differences from baseline in all participants:
***Po0.001, **Po0.01, males: &&&Po0.001, &&Po0.01 and &Po0.05 and females: #Po0.05. CCK, cholecystokinin; GLP-1, glucagon-like
peptide-1; PYY, total peptide YY; tAUC, total area under the curve; WL, weight loss.
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to normalise. Another study by Chearskul et al.19 with an 8-week
VLED (429 kcal per day) in 12 males with obesity who experienced
a 15% WL, did not report any changes in hunger or satiety
feelings, or CCK concentration, either fasting or postprandial,
immediately after the intervention, while in ketosis. However,
1 week later and without ketosis, a signiﬁcant reduction in
postprandial CCK was described (opposite to our study where no
changes were seen). Again, differences in the duration of the
stabilisation phase might have impacted on the results. In a
recently published study, Iepsen et al.41 reported a signiﬁcant
increase in fasting and postprandial total ghrelin, and PYY3–36 and
postprandial concentration of total GLP-1 after a 17% WL induced
with an 810 kcal per day diet over 8 weeks when participants were
out of ketosis. Differences in the hormones’ fractions measured
may account for some of the differences.
The increased hunger feelings and AG plasma concentrations
seen after refeeding (week 13) in the present study may have
important implications regarding WL outcomes. A recent study
has reported that the increase in appetite seen with WL was three
times larger than the corresponding reduction in total energy
expenditure, highlighting the important role the feedback control
of energy intake may have on long-term maintenance of a
reduced body weight.33
Throughout the study period, a mismatch was apparent
between subjective appetite feelings and anticipated relevant
appetite-related hormones. Among others, there was an increase
in hunger on day 3 (2 ± 1% WL), despite no changes in appetite
hormones except for insulin, and 5% WL, despite an increase in
GLP-1 AUC and a reduction in CCK. Even though this mismatch
can derive from lack of power, it is well known that the
appetite control system is extremely complex and subjective
feelings of appetite are not always correlated with the concentra-
tion of appetite-related hormones.42 Pre-lunch plasma concentra-
tions of total ghrelin and PYY were also found not to be associated
with lunch energy intake in healthy women.43 Moreover, a recent
review by Holt et al.44 concluded that self-reported appetite
ratings of appetite cannot reliably predict subsequent energy
intake.
As previously described, some sex differences were noted in
both subjective feelings of appetite and appetite hormones with
progressive WL. The fact that males, as opposed to females,
reported no increase in hunger throughout the study (despite
increased AG at week 13 (16 ± 2% WL)) is surprising. Females were
found to have a more sensitive neuronal response to food-related
visual cues, which can contribute to the sex differences reported
in the present study. Moreover, in our study, females had overall
higher fullness AUC, and overall higher basal and AUC for AG,
while males had overall higher hunger, desire to eat and PFC AUC.
This is in line with previous ﬁndings showing that females have a
higher satiating response to meals45 and lower ratings of hunger
and PFC.46 It needs to be acknowledged, nevertheless, that with
the VLED used in this study, males had a much larger energy
deﬁcit per day compared with females, which resulted in a larger
overall absolute WL, and this might have contributed to the sex
differences reported.
A strength of this study is its design; the fact that multiple
measurements were undertaken during progressive WL under
ketosis, and after a period of weight stabilisation and no ketosis.
This is important, given that ketosis is thought to modulate
appetite.12,22 Moreover, subjective and objective aspects of
appetite were assessed, both in fasting and after a meal.
Compliance with the intervention was monitored throughout
and was excellent. The choice of time points is also a strength,
given that it allowed to evaluate the impact of minimal, but
signiﬁcant WL (achieved at day 3), 5 and 10% WL, considered
necessary to achieved health beneﬁts,2 and large WL (16–17%)
under ketosis vs no ketosis, on appetite outcomes. It is also a
strength that we have adjusted for the increased risk of ﬁnding
statistically signiﬁcant differences by chance alone (by using
Bonferroni adjustment for multiple time comparisons and the
Benjamini—Hochberg method for multiple outcome variables).28
A limitation of this study is that it may be underpowered to
examine sex differences.
This study has important practical implications for patients,
clinicians and researchers alike. Opposite to previous reports that
the drive to eat is suppressed while under a ketogenic diet,19,22 we
have shown a transitory increase in hunger from baseline up to
3 weeks on a ketogenic VLED, which then disappear and only
come back after refeeding (and no ketosis). This information is of
importance because it can inﬂuence patients’ expectations and
adherence to VLEDs.
CONCLUSIONS
Progressive WL with a ketogenic VLED induces a transient increase
in fasting hunger feelings up to 5% WL (3 weeks), despite no
changes in AG and an increase in active GLP-1 AUC. A WL between
10 and 17% under ketosis is not associated with increased appetite
feelings or AG plasma concentration, despite reduced fasting
concentration of total PYY and CCK AUC. Increased hunger and
AG plasma concentration return with refeeding (no ketosis) and
weight stabilisation. Sex seems to modulate some of the changes in
appetite seen with WL, however, larger studies powered to detect
sex differences are required to conﬁrm these ﬁndings.
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